Nosology of Parkinson's disease: looking for the way out of a quagmire.

Abstract

The discovery of SNCA mutations pathogenic for autosomal-dominant Lewy body Parkinson's disease (PD) in 1997 heralded a revolution in understanding the molecular and genetic basis of PD. Indeed, it now is clear that Lewy body PD is one of many neurodegenerative parkinsonian disorders that result from nigrostriatal degeneration caused by diverse mechanisms. However, to capitalize on these new insights and facilitate efforts to improve the diagnosis and therapy of neurodegenerative movement disorders, it is timely to define a nosology for these diseases that is based on their genetic and molecular underpinnings, as proposed here.

• Authors: Mark S Forman, Virginia M-Y Lee, John Q Trojanowski
• Journal: Neuron (Neuron) Vol. 47 Issue 4 Pg. 479-82 (Aug 18 2005) ISSN: 0896-6273 [Print] United States
• PMID: 16102530 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• Nerve Tissue Proteins
• SNCA protein, human
• Synucleins
• alpha-Synuclein

Topics

• Animals
• Genetic Predisposition to Disease (genetics)
• Humans
• Mutation (genetics)
• Nerve Degeneration (genetics)
• Nerve Tissue Proteins (genetics)
• Parkinson Disease (classification, genetics)
• Substantia Nigra (metabolism, pathology, physiopathology)
• Synucleins
• Terminology as Topic
• alpha-Synuclein